Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | thymidylate kinase, putative | 0.0306 | 0.7167 | 0.5 |
Schistosoma mansoni | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Mycobacterium ulcerans | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Trichomonas vaginalis | thymidylate kinase, putative | 0.0306 | 0.7167 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0306 | 0.7167 | 0.5 |
Leishmania major | thymidylate kinase-like protein | 0.0306 | 0.7167 | 1 |
Wolbachia endosymbiont of Brugia malayi | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Loa Loa (eye worm) | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Mycobacterium leprae | probable thymidylate kinase Tmk (dTMP KINASE) (THYMIDYLIC ACID KINASE) (TMPK) | 0.0306 | 0.7167 | 0.5 |
Giardia lamblia | CDC8 | 0.0306 | 0.7167 | 0.5 |
Toxoplasma gondii | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0306 | 0.7167 | 0.5 |
Entamoeba histolytica | Thymidylate kinase, putative | 0.0306 | 0.7167 | 0.5 |
Schistosoma mansoni | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Plasmodium vivax | thymidylate kinase, putative | 0.0306 | 0.7167 | 0.5 |
Plasmodium falciparum | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Treponema pallidum | thymidylate kinase (tmk) | 0.0306 | 0.7167 | 0.5 |
Brugia malayi | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.038 | 1 | 1 |
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | 0.0306 | 0.7167 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0306 | 0.7167 | 1 |
Chlamydia trachomatis | thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Onchocerca volvulus | Putative thymidylate kinase | 0.0306 | 0.7167 | 0.5 |
Trypanosoma brucei | thymidylate kinase, putative | 0.0306 | 0.7167 | 0.5 |
Trypanosoma cruzi | thymidylate kinase, putative | 0.0306 | 0.7167 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.